Published in Ann Intern Med on August 20, 2002
Optimizing the control of disease infestations at the landscape scale. Proc Natl Acad Sci U S A (2007) 1.67
The effectiveness of vaccine day and educational interventions on influenza vaccine coverage among health care workers at long-term care facilities. Am J Public Health (2007) 1.36
Racial disparities in treatment preferences for rheumatoid arthritis. Med Care (2009) 1.21
Management of influenza symptoms in healthy adults. J Gen Intern Med (2003) 1.13
Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore. Emerg Infect Dis (2006) 1.11
The Saudi Thoracic Society guidelines for influenza vaccinations. Ann Thorac Med (2015) 1.06
From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination. Vaccine (2011) 1.05
Influenza-like illness among university students: symptom severity and duration due to influenza virus infection compared to other etiologies. J Am Coll Health (2011) 0.87
Economic analysis of influenza vaccination and treatment. Ann Intern Med (2003) 0.85
Cost-benefit analysis of influenza vaccination in a public healthcare unit. Ther Clin Risk Manag (2006) 0.85
Workplace vaccination and other factors impacting influenza vaccination decision among employees in Israel. Int J Environ Res Public Health (2010) 0.82
Policy resistance undermines superspreader vaccination strategies for influenza. PLoS Comput Biol (2013) 0.78
Employer-incurred health care costs and productivity losses associated with influenza. Hum Vaccin Immunother (2013) 0.76
Disease Interventions Can Interfere with One Another through Disease-Behaviour Interactions. PLoS Comput Biol (2015) 0.75
Economic analysis of influenza vaccination and treatment. Ann Intern Med (2003) 0.75
Economic analysis of influenza vaccination and treatment. Ann Intern Med (2003) 0.75
Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions. PLoS Comput Biol (2017) 0.75
Economic evaluations of neuraminidase inhibitors to control influenza. Expert Rev Pharmacoecon Outcomes Res (2003) 0.75
Predictive and Reactive Distribution of Vaccines and Antivirals during Cross-Regional Pandemic Outbreaks. Influenza Res Treat (2011) 0.75
Economic analysis of influenza vaccination and treatment. Ann Intern Med (2003) 0.75
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med (2006) 4.44
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Compliance with results reporting at ClinicalTrials.gov. N Engl J Med (2015) 4.17
Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA (2010) 4.13
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg (2009) 4.10
Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA (2008) 4.06
Validation of European System for Cardiac Operative Risk Evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg (2002) 3.86
Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med (2005) 3.83
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA (2005) 3.72
Conversion of cardiovascular conference abstracts to publications. Circulation (2012) 3.71
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2013) 3.60
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation. J Am Coll Cardiol (2009) 3.54
Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation (2006) 3.45
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg (2009) 3.45
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA (2011) 3.44
Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation (2006) 3.38
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Association between physician billing and cardiac stress testing patterns following coronary revascularization. JAMA (2011) 3.19
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07
Use of aldosterone antagonists in heart failure. JAMA (2009) 3.00
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96
Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database. Ann Surg (2004) 2.95
Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med (2003) 2.92
A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons. Ann Thorac Surg (2002) 2.91
Outcomes following transcatheter aortic valve replacement in the United States. JAMA (2013) 2.88
The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg (2003) 2.86
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86
Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke (2004) 2.86
Identifying frailty in hospitalized older adults with significant coronary artery disease. J Am Geriatr Soc (2006) 2.82
Use of both internal thoracic arteries in diabetic patients increases deep sternal wound infection. Ann Thorac Surg (2007) 2.82
A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation (2006) 2.81
The value of statistical analysis plans in observational research: defining high-quality research from the start. JAMA (2012) 2.69
Racial differences in survival after in-hospital cardiac arrest. JAMA (2009) 2.65
Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med (2012) 2.64
Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol (2011) 2.63
Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection. Ann Thorac Surg (2007) 2.60
Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating. Ann Thorac Surg (2007) 2.59
Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J (2005) 2.55
Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol (2008) 2.55
Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study). Circulation (2012) 2.54
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation (2008) 2.53
Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation (2010) 2.53
Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation (2006) 2.51
Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv (2008) 2.48
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients. Hypertension (2009) 2.37
The complex relationship between pediatric cardiac surgical case volumes and mortality rates in a national clinical database. J Thorac Cardiovasc Surg (2009) 2.37
Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg (2008) 2.35
Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg (2009) 2.35
Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J (2008) 2.33